Search

Search Constraints

You searched for: Author/Creator Mamedov, Alexandre

Search Results

1. 1: Elective Pelvic Nodal Irradiation with a Simultaneous Hypofractionated Integrated Prostate Boost for Localized High Risk Prostate Cancer: Long Term Results from a Prospective Clinical Trial. (October 2021)

2. 48: Intermittent Androgen Deprivation Therapy Plus Comprehensive Stereotactic Radiotherapy for Oligometastatic Prostate Cancer (CROP). (October 2021)

3. 80 Toxicity and Quality of Life Results from a Randomized Phase II Trial of HDR Monotherapy for Low and Intermediate-Risk Prostate Cancer. (October 2019)

4. 8: Dosimetric Predictors of Toxicity and Quality of Life Following Single Fraction High Dose-Rate Prostate Brachytherapy. (October 2021)

5. A natural history of lower-risk myelodysplastic syndromes with ring sideroblasts: an analysis of the MDS-CAN registry. Issue 13 (10th November 2022)

6. Accelerating prostate stereotactic ablative body radiotherapy: Efficacy and toxicity of a randomized phase II study of 11 versus 29 days overall treatment time (PATRIOT). (August 2020)

7. Dose escalation for prostate stereotactic ablative radiotherapy (SABR): Late outcomes from two prospective clinical trials. Issue 2 (May 2018)

8. Dose-escalation of five-fraction SABR in prostate cancer: Toxicity comparison of two prospective trials. Issue 1 (January 2016)

9. Dosimetric predictors of toxicity and quality of life following prostate stereotactic ablative radiotherapy. (March 2020)

10. Elective pelvic nodal irradiation with a simultaneous hypofractionated integrated prostate boost for localized high risk prostate cancer: Long term results from a prospective clinical trial. (October 2021)